AtriCure (ATRC)
AtriCure EBITDA Margin TTM: -4.66%
View ATRC EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
ATRC EBITDA Margin TTM Rankings
| Overall | 11th percentile | 3413 of 3847 |
| Sector | 36th percentile | 285 of 450 in Healthcare |
| Industry | 31st percentile | 44 of 64 in Medical Instruments & Supplies |
ATRC EBITDA Margin TTM Range, Past 5 Years
| Minimum | -32.12% | Jun 2007 |
| Maximum | -0.08% | Mar 2011 |
| Average | -11.15% |
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these ATRC related companies
ATRC News
Listen to $ATRC Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eG8
about 24 days ago by earningscast
about 24 days ago by earningscast
$ATRC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Kwl
about 44 days ago by MarketBrief
about 44 days ago by MarketBrief
Leerink Swann Starts AtriCure Inc. (ATRC) at Outperform; Positive Sales Growth Inflection Point
Mar 20, 7:14AM Street Insider
Mar 20, 7:14AM Street Insider
Listen to $ATRC Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2a3D
about 90 days ago by earningscast
about 90 days ago by earningscast
AtriCure to Announce Fourth Quarter and Full Year 2011 Financial Results
Feb 21, 3:00PM Business Wire
Feb 21, 3:00PM Business Wire
Canaccord Genuity Reiterates a 'Buy' on AtriCure (ATRC); ATRC Has Productive STS
Feb 02, 9:36AM Street Insider
Feb 02, 9:36AM Street Insider
$ATRC Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
about 163 days ago by Benzinga
about 163 days ago by Benzinga
Listen to $ATRC at piper jaffray health care conference - live at 10:00 AM, ondemand after - http://stks.co/1Jy5
about 179 days ago by earningscast
about 179 days ago by earningscast
$ATRC up 24.2%. Panel Recommends FDA Approval for Atrial Fibrillation Treatment
about 213 days ago by lewisgreen
about 213 days ago by lewisgreen
Great news for cheaper and less invasive treatment from $ATRC : http://on.wsj.com/oMFNyI
about 326 days ago by Mdhemp
about 326 days ago by Mdhemp
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATRC | 8.99 | +0.58 | +6.90% | 148.16M |
| ATR | 50.61 | -0.45 | -0.88% | 3.366B |
| ATPG | 5.15 | +0.00 | +0.00% | 268.06M |
| ATO | 32.67 | -0.24 | -0.73% | 2.947B |
| ATNI | 32.59 | -0.04 | -0.12% | 503.52M |
| ATML | 7.29 | +0.12 | +1.67% | 3.287B |
| BABY | 11.22 | +0.02 | +0.18% | 330.32M |
| BAB | 29.70 | +0.01 | +0.03% | |
| BAA | 4.37 | +0.16 | +3.80% | 875.27M |
| BA | 70.00 | -1.39 | -1.95% | 52.35B |
